Eli Lilly <a href="https://www.reuters.com/markets/companies/LLY.N" target="_blank">(LLY.N)</a> on Tuesday raised its annual forecasts after beating estimates for quarterly results, driven by strong demand for its new diabetes drug Mounjaro, ahead of a decisiā¦